Warfarin-induced skin necrosis associated with acquired protein C deficiency

Australasian Journal of Dermatology

Volumn 44, Issue 1, 2003, Pages 57-61

  Parsi, Kurosh ^a   Younger, Ian ^b   Gallo, John ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NONE

Author keywords

Calciphylaxis; Cardiomyopathy; Coumarin; Panniculitis

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; CAPTOPRIL; DIGOXIN; ENOXAPARIN; FLUCLOXACILLIN; FRESH FROZEN PLASMA; FUROSEMIDE; GENTAMICIN; LOW MOLECULAR WEIGHT HEPARIN; METRONIDAZOLE; PENICILLIN DERIVATIVE; PENICILLIN G; PROTEIN C; VITAMIN K GROUP; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; CELLULITIS; CONGESTIVE CARDIOMYOPATHY; DEBRIDEMENT; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG INDUCED DISEASE; FEMALE; HUMAN; LIVER FUNCTION TEST; PROTEIN C DEFICIENCY; PROTHROMBIN TIME; SKIN BIOPSY; SKIN GRAFT; SKIN NECROSIS; SKIN TOXICITY; THROMBOEMBOLISM; THROMBOPHLEBITIS;

ADULT; ANTICOAGULANTS; CARDIOMYOPATHY, DILATED; CHOLELITHIASIS; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; FEMALE; HUMANS; LEG; NECROSIS; PROTEIN C DEFICIENCY; WARFARIN;

EID: 0037325460     PISSN: 00048380     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-0960.2003.00639.x     Document Type: Article

References (39)

1. Stern RS, Wintroub BU. Cutaneous reactions to drugs. In: Freedberg IM, Eisen AZ, Klaus W, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB (eds). Fitzpatrick's Dermatology in General Medicine, 5th edn. New York: McGraw-Hill, 1999; 1633-42 (1638).
2. De Franzo AJ, Marasco P, Argenta LC. Warfarin-induced necrosis of the skin. Ann. Plast. Surg. 1993; 34: 203-8.
3. Eby CS. Warfarin-induced skin necrosis. Hematol. Oncol. Clin. North Am. 1993; 7: 1291-300.
4. Scarff CE, Baker C, Hill P, Foley P. Late-onset warfarin necrosis. Australas. J. Dermatol. 2002; 43: 202-6.
5. Vigano-D'Angelo S, Comp PC, Esmon CT, D'Angelo A. Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease states. Clin. Invest. 1986; 77: 416-25.
6. McGehee WG, Klotz TA, Epstein DJ, Rapaport SI. Coumarin necrosis associated with hereditary protein C deficiency. Ann. Intern. Med. 1984; 100: 59-60.
7. Goldberg SL, Orthner CL, Yalisove BL, Elgart ML, Kessler CM. Skin necrosis following prolonged administration of coumarin in a patient with inherited protein C deficiency. Am. J. Hematol. 1991; 38: 64-6.
8. Sternberg ML, Pettyjohn FS. Warfarin sodium-induced skin necrosis. Ann. Emerg. Med. 1995; 26: 94-7.
9. Broekmans AW, Bertina RM, Loeliger EA, Hofmann V, Klingemann HG. Protein C and the development of skin necrosis during anticoagulant therapy. Thromb. Haemost. 1983; 49: 251.
10. Rose VL, Kwaan HC, Williamson K, Hoppensteadt D, Walenga J, Fareed J. Protein C antigen deficiency and warfarin necrosis. Am. J. Clin. Pathol. 1986; 86: 653-5.
11. Samama M, Horellou MH, Soria J, Conard J, Nicolas G. Successful progressive anticoagulation in a severe protein C deficiency and previous skin necrosis at the initiation of oral anticoagulation treatment. Thromb. Haemost. 1984; 51: 132-3.
12. Grimaudo V, Gueissaz F, Hauert J, Sarraj A, Kruithof EK, Bachmann F. Necrosis of skin induced by coumarin in a patient deficient in protein S. BMJ 1989; 298: 233-4.
13. Craig A, Taberner DA, Fisher AH, Foster DN, Mitra J. Type 1 protein S deficiency and skin necrosis. Postgrad. Med. J. 1990; 66: 389-91.
14. Gailani D, Reese EPJ. Anticoagulant-induced skin necrosis in a patient with hereditary deficiency of protein S. Am. J. Hematol. 1999; 60: 231-6.
15. Wattiaux MJ, Herve R, Robert A, Cabane J, Housset B, Imbert JC. Coumarin-induced skin necrosis associated with acquired protein S deficiency and antiphospholipid antibody syndrome. Arthritis Rheum. 1994; 37: 1096-100.
16. Cheng A, Scheinfeld NS, McDowell B, Dokras AA. Warfarin skin necrosis in a postpartum woman with protein S deficiency. Obstet. Gynecol. 1997; 90: 671-2.
17. Dahlback B. New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg 506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis. Thromb. Haemost. 1995; 74: 139-48.
18. Keihl R, Hellstern P, Wenzel E. Hereditary antithrombin III (AT III) deficiency and atypical localization of a coumarin necrosis. Thromb. Res. 1987; 45: 191-3.
19. Colman RW, Rao AK, Rubin RN. Warfarin skin necrosis in a 33-year-old woman. Am. J. Hematol. 1993; 43: 300-3.
20. Koster T, Rosendaal F, Briet E, Van der Meer FJM, Colly LP, Trienekens PH, Poort SR, Vandenbroucke JP. Protein C deficiency in a controlled series of unselected outpatients: An infrequent but clear risk for venous thrombosis (Leiden Thrombophilia Study). Blood 1995; 85: 2756-61.
21. Allaart CF, Poort S, Rosendaal FR, Reitsma PH, Bertina RM, Briet E. Increased risk of venous thrombosis in carriers of hereditary protein C deficiency. Lancet 1993; 341: 134-8.
22. Miletich J, Sherman L, Broze GJ. Absence of thrombosis in subjects with heterozygous protein C deficiency. N. Engl. J. Med. 1987; 317: 991-6.
23. Tait RC, Walker ID, Reitsma PH, Islam S, McCall F, Poort SR, Conkie JA, Bertina RM. Prevalence of protein C deficiency in the healthy population. Thromb. Haemost. 1995; 73: 87-93.
24. Branson HE, Katz R, Griffin JH. Inherited protein C deficiency and coumarin-responsive chronic relapsing purpura fulminans in a newborn infant. Lancet 1983; 2: 1165-8.
25. Marciniak E, Wilson HD, Marlar RA. Neonatal purpura fulminans: A genetic disorder related to absence of protein C in blood. Blood 1985; 65: 15-20.
26. Presgrave P, Ma D. Genetic predisposition to venous thrombo-embolism: Molecular basis and a practical guide to management. Aust. NZ J. Phleb. 2000; 4: 39-45.
27. Taher A, Shamsseddine A, Saghir N, Seoud M, Mourad F, Dabajah B, Khalil A. Acquired protein C deficiency following cisplatinum-navelbine administration for locally advanced breast cancer. Case report. Eur. J. Gynaecol. Oncol. 1999; 20: 323-4.
28. Feffer SE, Carmosino LS, Fox RL. Acquired protein C deficiency in patients with breast cancer receiving cyclophosphamide, methotrexate, and 5-fluorouracil. Cancer 1989; 63: 1303-7.
29. Smith OP, White B, Vaughan D, Raffterty M, Claffey L, Lyons B, Casey W. Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans. Lancet 1997; 350: 1590-3.
30. Ruiz-Arguelles GJ, Ruiz-Arguelles A, Deleze M, Alarcon-Segovia D. Acquired protein C deficiency in a patient with primary antiphospholipid syndrome. Relationship to reactivity of anticardiolipin antibody with thrombomodulin. J. Rheumatol. 1989; 16: 381-3.
31. Korsten S, Reis HE. Erworbener Protein-C-Mangel bei Colitis ulcerosa. Ursache thromboembolischer Komplikationen. Dtsch. Med. Wochenschr. 1992; 117:419-24 (In German with abstract in English).
32. Gruppo R, Degrauw A, Fogelson H, Glauser T, Balasa V, Gartside P. Protein C deficiency related to valproic acid therapy: A possible association with childhood stroke. J. Pediatr. 2000; 137: 714-18.
33. Mehta RL, Scott G, Sloand JA, Francis CW. Skin necrosis associated with acquired protein C deficiency in patients with renal failure and calciphylaxis. Am. J. Med. 1990; 88: 252-7.
34. Warkentin TE. Heparin-induced thrombocytopenia: A ten-year retrospective. Annu. Rev. Med. 1999; 50: 129-47.
35. Gerson WT, Dickerman JD, Bovill EG, Golden E. Severe acquired protein C deficiency in purpura fulminans associated with disseminated intravascular coagulation: Treatment with protein C concentrate. Pediatrics 1993; 91: 418-22.
36. Fisher CJJ, Yan SB. Protein C levels as a prognostic indicator of outcome in sepsis and related diseases. Crit. Care Med. 2000; 28: 49-56.
37. Yan SB, Helterbrand JD. Low levels of protein C are associated with poor outcome in severe sepsis. Chest 2001; 120: 915-22.
38. Mehta A, Hoffbrand V. Disorders of coagulation II: Acquired. In: Haematology at a Glance. Oxford: Blackwell Science, 2000; 88-9.
39. Argaud L, Guerin C, Thomas L, Fournier G. Extensive coumarin-induced skin necrosis in a patient with acquired protein C deficiency. Intensive Care Med. 2001; 27: 1555.